U.S. Markets close in 15 mins

The Global Oligonucleotide Synthesis Market 2019-2024: Analyzed by Product, Type (Custom, Pre Design), Application (PCR, DNA, RNAi, Research, Therapeutic), End-user and Region

DUBLIN, May 10, 2019 /PRNewswire/ -- The "Oligonucleotide Synthesis Market by Product, Type (Custom, Pre design), Application (PCR, DNA, RNAi, Research, Therapeutic), End User - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7% during the forecast period.

This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques. The increasing applications of oligos in nucleic acid array-based technologies, library preparation, NGS, genomics, nucleic acid-based detection, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology are also driving the growth of this market.

Hospitals accounted for the largest share of the oligonucleotide synthesis market, by end user, in 2018

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and hospitals. Hospitals held the largest share of the market in 2018 due to the significant number of inpatient and outpatient visits in hospitals and the requirement of oligonucleotide drugs to cater to the demand of the patient pool suffering from diseases such as Duchenne muscular dystrophy, spinal muscular atrophy, and hepatic veno-occlusive disease.

Synthesized oligos dominated the oligonucleotide synthesis market, by product, in 2018

Based on product, the market is segmented into synthesized oligos, reagents, and equipment. The synthesized oligos segment held the largest share of the market in 2018 and is estimated to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the increasing applications of synthesized oligos in therapeutics, research, and diagnostics.

North America to dominate the market during the forecast period

Geographically, the oligonucleotide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest regional market for oligonucleotide synthesis. The North American market is also estimated to grow at the highest CAGR during the forecast period owing to the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the North American region.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Attractive Opportunities in the Oligonucleotide Synthesis Market
4.2 Synthesized Oligos Market, By Product
4.3 Synthesized Oligos Market, By Type
4.4 Asia Pacific: Oligonucleotide Synthesis Market, By Research Application and Country (2019)
4.5 Oligonucleotide Synthesis Market, By Therapeutic Application
4.6 Oligonucleotide Synthesis Market, By End User
4.7 Geographic Snapshot: Oligonucleotide Synthesis Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications
5.2.1.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
5.2.1.3 Rise in Venture Capital Investments
5.2.2 Market Restraints
5.2.2.1 Price Erosion of Synthesized Oligos
5.2.2.2 Lack of A Unified Set of Regulations for Therapeutic Oligos
5.2.3 Market Opportunities
5.2.3.1 Emerging Asian Markets
5.2.4 Market Challenges
5.2.4.1 Large-Scale Synthesis of Oligos
5.2.4.2 Delivery of Oligonucleotide Drugs to Specific Targets

6 Oligonucleotide Synthesis Market, By Product
6.1 Introduction
6.2 Synthesized Oligos
6.2.1 Synthesized Oligos Market, By Product
6.2.1.1 Oligonucleotide-Based Drugs
6.2.1.1.1 Oligonucleotide-Based Drugs Dominate the Synthesized Oligos Market, By Product
6.2.1.2 Primers
6.2.1.2.1 Growing Research Activity Drives the Market for Primers
6.2.1.3 Probes
6.2.1.3.1 Probes are Designed to Detect Various Infectious Agents
6.2.1.4 Intermediate-Scale Synthesized Oligos
6.2.1.4.1 The Increasing Demand for Synthesized Oligos and Innovations in Manufacturing Techniques Drives the Market.
6.2.1.5 Large-Scale Synthesized Oligos
6.2.1.5.1 Increasing Demand for Large Quantities of Modified and Unmodified Oligos to Drive the Market
6.2.1.6 Linkers & Adaptors
6.2.1.6.1 Linkers are Used to Add Restriction Sites in DNA
6.2.2 Synthesized Oligos Market, By Type
6.2.2.1 Predesigned Oligos
6.2.2.1.1 Predesigned Oligos Dominate the Oligonucleotide Synthesis Market, By Type
6.2.2.2 Custom Oligos
6.2.2.2.1 Increasing Number of Clinical and Pre-Clinical Research to Drive the Market for Custom Oligos
6.3 Reagents
6.4 Equipment

7 Oligonucleotide Synthesis Market, By Application
7.1 Introduction
7.2 Therapeutic Applications
7.2.1 DNA & Antisense Oligonucleotide-Based therapies
7.2.1.1 DNA & Antisense Oligos Form the Largest Segment in the Therapeutic Applications Market
7.2.2 RNAi Oligonucleotide-Based therapies
7.2.2.1 Significant Initiatives By Pharmaceutical and Biotechnology Companies to Drive the Market for RNAi Oligonucleotide-Based therapies
7.2.3 Cpg Oligonucleotide-Based therapies
7.2.3.1 This Market Segment is in the Initial Stage, and Significant Growth Might Be Observed During the Forecast Period
7.3 Diagnostic Applications
7.4 Research Applications
7.4.1 PCR
7.4.1.1 Increasing Use of PCR in Research to Drive Market Growth
7.4.2 QPCR
7.4.2.1 Its Cost-Effectiveness, Concurrent Monitoring of Expression Levels of Multiple Genetic Messages in Real Time, and High Sensitivity Make QPCR A Vital Tool for Quantification of Nucleic Acids
7.4.3 Sequencing
7.4.3.1 Advancements in Sequencing Technologies and Low Cost to Drive the Market for Sequencing Applications
7.4.4 Gene Synthesis
7.4.4.1 Increasing Applications of Gene Synthesis and Low Cost to Drive the Market for This Application Segment
7.4.5 Other Research Applications

8 Oligonucleotide Synthesis Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals are the Largest End Users of Oligos Due to the Significant Number of Inpatient and Outpatient Visits
8.3 Academic Research Institutes
8.3.1 Academic Researchers Primarily Use Oligos for Genetic Engineering, PCR Activities, and High-Throughput Sequencing - A Major Factor Driving Market Growth
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Growing Applications of Oligos in Drug Discovery & Therapeutics to Drive the Demand for Oligonucleotide Synthesis Among these End Users
8.5 Diagnostic Laboratories
8.5.1 Diagnostic Laboratories Register High Growth in the Oligonucleotide Synthesis Market Due to the Increasing Significance of Oligos in Molecular Diagnostics

9 Oligonucleotide Synthesis Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Government Initiatives and Strategic Developments By Market Players to Drive Market Growth in the Country
9.2.2 Canada
9.2.2.1 Growing Initiatives and Funding in Synthetic Biology and Genomics to Drive the Market in the Country
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic Research Institutes to Support Market Growth
9.3.2 France
9.3.2.1 Government Initiatives to Boost R&D Activities in the Country
9.3.3 UK
9.3.3.1 Growth in the Life Science Industry to Drive the Market for Oligonucleotides Synthesis in the UK
9.3.4 Italy
9.3.4.1 Increasing Research Activities to Drive the Market for Oligonucleotides Synthesis in Italy
9.3.5 Spain
9.3.5.1 Government Initiatives to Drive the Market for Oligonucleotide Synthesis
9.3.6 RoE
9.4 Asia Pacific
9.4.1 China
9.4.1.1 Government Initiatives to Strengthen the Biotechnology Industry in China
9.4.2 Japan
9.4.2.1 Increasing Awareness Through Conferences and Workshops to Drive the Market in the Country
9.4.3 India
9.4.3.1 Government Initiatives to Promote Synthetic Biology to Drive the Market in the Country
9.4.4 RoAPAC
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Development in Genomics to Aid Market Growth in Brazil
9.5.2 Mexico
9.5.2.1 Increasing Awareness About Advancements in Oligonucleotides to Drive the Market
9.5.3 RoLATAM
9.6 Middle East & Africa

10 Competitive Landscape
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Partnerships, Agreements, Contracts, and Collaborations
10.3.2 Product Launches, Upgrades, and Approvals
10.3.3 Expansions
10.3.4 Acquisitions
10.4 Competitive Leadership Mapping (2017)
10.4.1 Vanguards
10.4.2 Innovators
10.4.3 Dynamic Players
10.4.4 Emerging Players
10.5 Competitive Leadership Mapping for Start-Ups (2018)
10.5.1 Progressive Companies
10.5.2 Starting Blocks
10.5.3 Responsive Companies
10.5.4 Dynamic Companies
10.6 MnM Dive-Vendor Comparison Matrix for Start-Ups: Oligonucleotide Synthesis Market

11 Company Profiles
11.1 Agilent Technologies
11.2 ADTBio
11.3 Bioautomation (Acquired by LGC)
11.4 Bio-Synthesis Inc.
11.5 Eurofins Genomics
11.6 Eurogentec
11.7 GE Healthcare
11.8 Genscript
11.9 Genedesign (Part of Ajinomoto
11.10 Integrated DNA Technologies (Acquired by Danaher Corporation)
11.11 LGC Biosearch Technologies
11.12 Merck KGaA
11.13 Nitto Denko Avecia
11.14 Thermo Fisher Scientific
11.15 TriLink Biotechnologies (Part of Maravai Lifesciences)

For more information about this report visit https://www.researchandmarkets.com/r/7wrh6s

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision

View original content:http://www.prnewswire.com/news-releases/the-global-oligonucleotide-synthesis-market-2019-2024-analyzed-by-product-type-custom-pre-design-application-pcr-dna-rnai-research-therapeutic-end-user-and-region-300848050.html